Aurora-A activation, correlated with hypoxia-inducible factor-1α, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aurora-A activation, correlated with hypoxia-inducible factor-1α, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 103, Issue 8, Pages 1586-1594
Publisher
Wiley
Online
2012-05-16
DOI
10.1111/j.1349-7006.2012.02332.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma
- (2011) B. B. Y. Ma et al. ANNALS OF ONCOLOGY
- Histone H3 covalent modifications driving response of BCR-ABL1+ cells sensitive and resistant to imatinib to Aurora kinase inhibitor MK-0457
- (2011) Manuela Mancini et al. BRITISH JOURNAL OF HAEMATOLOGY
- Aurora-B Mediated ATM Serine 1403 Phosphorylation Is Required for Mitotic ATM Activation and the Spindle Checkpoint
- (2011) Chunying Yang et al. MOLECULAR CELL
- Overexpression of Active Aurora-C Kinase Results in Cell Transformation and Tumour Formation
- (2011) Jabbar Khan et al. PLoS One
- Elevated Beclin 1 expression is correlated with HIF-1α in predicting poor prognosis of nasopharyngeal carcinoma
- (2010) Xiang-Bo Wan et al. Autophagy
- Inhibition of Aurora-A results in increased cell death in 3-dimensional culture microenvironment, reduced migration and is associated with enhanced radiosensitivity in human nasopharyngeal carcinoma
- (2010) Xiang-Bo Wan et al. CANCER BIOLOGY & THERAPY
- Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck
- (2010) Marta Osorio Rodríguez et al. CANCER BIOLOGY & THERAPY
- Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
- (2010) Anne M. Traynor et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway
- (2010) L.-h. Wang et al. CANCER RESEARCH
- Pharmacodynamic Trial of Nimotuzumab in Unresectable Squamous Cell Carcinoma of the Head and Neck: A SENDO Foundation Study
- (2010) F. Rojo et al. CLINICAL CANCER RESEARCH
- Serologic Antienzyme Rate of Epstein-Barr Virus DNase-Specific Neutralizing Antibody Segregates TNM Classification in Nasopharyngeal Carcinoma
- (2010) Jie Xu et al. JOURNAL OF CLINICAL ONCOLOGY
- Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation
- (2009) A. Talavera et al. CANCER RESEARCH
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- (2009) James A Bonner et al. LANCET ONCOLOGY
- Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma
- (2009) X. Shang et al. MOLECULAR CANCER THERAPEUTICS
- Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model
- (2009) S. L. C. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Aurora-A suppresses epithelial–mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells
- (2008) Xiang-Bo Wan et al. CARCINOGENESIS
- Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer
- (2008) Y. Nadler et al. CLINICAL CANCER RESEARCH
- Transcriptional Regulation of Serine/Threonine Kinase-15 (STK15) Expression by Hypoxia and HIF-1
- (2008) Alexandra Klein et al. MOLECULAR BIOLOGY OF THE CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now